Sichuan Kelun Pharmaceutical Hits Day High with 8.9% Surge

Sichuan Kelun Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 8.9% on July 1, 2026. The stock reached an intraday high of CNY 42.37, showcasing notable activity in the pharmaceuticals and biotechnology sector. Over the past week, Sichuan Kelun has outperformed the China Shanghai Composite, with a weekly increase of 11.57% compared to the index's modest 0.04% rise. The company's one-month performance also stands out, with a gain of 15.85% against the composite's 1.35%. Year-to-date, the stock has surged by 42.93%, significantly outpacing the broader market's 3.62% increase. Despite these short-term gains, the company has faced challenges, reporting negative results for six consecutive quarters. Key financial metrics indicate a net profit of CNY 1,141.6 million, reflecting a decline of 32.93%. Additionally, the return on capital employed (ROCE) is at a low of 6.58%. With a market capitalization of CNY 39,696 million, Sichuan Kelun continues to navigate a complex financial landscape while demonstrating resilience in its recent stock performance.